Investment
Features
FeesSafety
Academy
More
Pluang+

Compare JPMorgan Chase & Co (JPM) vs RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) (RELX) Price & Performance

JPMorgan Chase & CoTrade
RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)Trade

Price performance (Past 24H)

Key statistics

JPMorgan Chase & Co vs RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) — how do they compare? JPMorgan Chase & Co trades at $334.31 (market cap $890.37B), while RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) trades at $37.91 (market cap $63.89B). The key difference: JPMorgan Chase & Co is far larger — about 13.9× RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)'s market cap, and RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) pays the higher dividend (2.47%). Which is the better fit depends on your goals.

JPMRELX
Market Cap
$890.37B$63.89B
Volume
10,236,4122,760,502
Sector
FinancialsIndustrials
52-Week High
$365.18$46.80
52-Week Low
$282.84$27.73
Typical Hold Time
127 Days—
Enterprise Value
$1.40T$75.40B
Dividend Yield
1.97%2.47%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

JPMorgan Chase & Co

JPMorgan Chase (JPM) trades at $331.43, down 0.86% on the day, with a bearish technical signal. The stock shows strong fundamentals with a P/E of 14.06, net income margin of 32.48%, and ROE of 17.91%. Recent earnings beat expectations in Q1 and Q2 2026 but missed in Q3. Revenue has grown from $128.6B in 2022 to $181.85B in 2025, with net income reaching $57.05B. Analyst consensus is a Moderate Buy with a $373.36 price target, indicating 12.6% upside. CEO Jamie Dimon's recent shareholder letter highlighted economic risks, including geopolitical tensions and inflation.

JPMorgan's outlook is supported by solid profitability and analyst optimism, but risks include volatile cash flows, rising debt levels, and macroeconomic headwinds. The stock's current valuation offers potential upside relative to consensus targets, though investors should monitor earnings consistency and management's guidance amid ongoing market uncertainties.

RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)

RELX trades at $36.70, up 0.44% with neutral technical signals. The company demonstrates strong profitability with 23.27% net margins and 132.36% ROE, though valuation metrics appear elevated with P/E of 22.21 and P/B of 38.89. Recent earnings show mixed results with Q2 2026 beating expectations while Q4 2025 missed. Analyst sentiment remains positive with 71% buy ratings and consensus price target of $26.00.

The investment case balances strong fundamentals against premium valuation. Growth catalysts include AI-driven product adoption and margin expansion, while risks involve competitive pressures and valuation concerns. With solid cash flow generation and institutional support, RELX offers quality exposure but requires monitoring of valuation multiples and competitive dynamics.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

JPM
82% Buy18% Sell
Avg holding period · 127 Days
RELX

No sentiment data available yet.

Top news

Latest headlines on both assets

About JPMorgan Chase & Co

JPMorgan Chase & Co. provides global financial services and retail banking. The Company provides services such as investment banking, treasury and securities services, asset management, private banking, card member services, commercial banking, and home finance. JP Morgan Chase serves business enterprises, institutions, and individuals.

Read more on JPM →

About RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)

RELX PLC is a UK-based information and analytics company operating across four segments: Risk (fraud prevention and compliance analytics via LexisNexis Risk Solutions), Scientific, Technical & Medical (Elsevier's research and clinical content), Legal (LexisNexis Legal & Professional's research tools), and Exhibitions (RX's trade events). It serves professional, business, and government customers worldwide.

Read more on RELX →